Testing Cerebrolysin for prolonged brain injury after bleeding stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation, Mental health clinical trials.
This study tests whether Cerebrolysin can improve recovery in people who remain in a vegetative or minimally conscious state more than 4 weeks after a bleeding stroke. It also tracks safety, to make sure the treatment is not causing harmful side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a bleeding stroke confirmed by CT or MRI
- It must be more than 4 weeks since the stroke started
- You must currently be in a vegetative state or minimally conscious state
- Age must be 19 to 80
- A caregiver or legal representative must be able to consent in writing
- You must not have major exclusion issues like certain EEG findings or serious organ disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.
This trial is testing a brain function evaluation system to help understand and possibly improve care for people with disorders of consciousness caused by brain injury, stroke, or lack of oxygen. It is for both acute (recent) and prolonged (lasting) cases.
This study tests whether a medicine called Cerebrolysin can help improve speech in people who have trouble speaking after a stroke. It is for Korean speakers who had their first stroke within the last month.
This trial tests whether Cerebrolysin (a medication given through an IV) can help improve recovery after a stroke when given after a successful clot-removal procedure that happened several hours after the stroke began. It is being tested in people who had a large-vessel stroke in the front of the brain and meets certain imaging criteria. The goal is to see if the drug can reduce disability and improve recovery.
This trial studies treatments to help people regain consciousness after an intracerebral hemorrhage (a bleeding stroke inside the brain). It focuses on adults who are unresponsive to commands within 48 hours, likely from certain bleeding locations, and who meet specific safety and language requirements.
This study tests a natural substance (called BCS) to see if it can help people who have had a severe stroke and are not fully awake. It looks at whether giving BCS soon after a stroke can improve recovery.
Hear when a new Disorder of Consciousness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.